SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001213900-23-020278
Filing Date
2023-03-15
Accepted
2023-03-15 15:32:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G ea175266-13ga1eeurope_neuro.htm SC 13G/A 38815
  Complete submission text file 0001213900-23-020278.txt   40327
Mailing Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562
Business Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562 972-9-9531142
NeuroSense Therapeutics Ltd. (Subject) CIK: 0001875091 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93172 | Film No.: 23734933
SIC: 2834 Pharmaceutical Preparations

Mailing Address MADISON BUILDING MIDTOWN QUEENSWAY J1 GX11 1AA
Business Address MADISON BUILDING MIDTOWN QUEENSWAY J1 GX11 1AA 350 200 79000
E Europe Ltd (Filed by) CIK: 0001901478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: J1 | Fiscal Year End: 1231
Type: SC 13G/A